Pan-Asia Index Rebalances/ Events/ Delta One, Periscope Analytics

Brian Freitas

Highly experienced ex-Delta One trader with 17 years of experience trading arbitrage and related strategies across Asian markets.

Exempt Financial Adviser (EFA) under CrossASEAN Research Pte Ltd.

It is important to note that the information provided by Periscope Analytics is based on publicly available data and own knowledge, which has been gathered and synthesized from a variety of sources. While every effort has been made to ensure the accuracy and completeness of the information provided, it is not guaranteed to be free from errors or omissions.

All forecasts and estimates are based on information that has been obtained from public sources that are considered to be reliable. The sources include, but are not limited to, company announcements, exchange filings, ETF and other passive investment vehicle holdings, and free float and volume data from third-party data providers. Periscope Analytics does not guarantee the accuracy and completeness of the forecasts, estimates and/or other information.

Pan-Asia Index Rebalances/ Events/ Delta One

Orix Corporation: Osaka Casino Resort Partnership with MGM Stakes Out Earliest Claim Among Peers

Event-Driven

<div><p>An hour ago, <a href="https://www.smartkarma.com/entities/astellas-pharma-inc" target="_blank" rel="noopener" data-smartkarma-citation="entities:6091:1">Astellas Pharma (4503 JP)</a> announced a buyback for up to 32mm shares (around 1.7% of shares outstanding excluding Treasury shares) and up to ¥50 billion to be conducted between 1 November 2019 and 31 January 2020. All shares bought back will be cancelled on 14 February 2020.</p></div><div><p>We take a look at some of the details around the buyback and the impact of the previous buyback on the share price over the buyback period.</p></div>

An hour ago, Astellas Pharma (4503 JP) announced a buyback for up to 32mm shares (around 1.7% of shares outstanding excluding Treasury shares) and up to ¥50 billion to be conducted between 1 November 2019 and 31 January 2020. All shares bought back will be cancelled on 14 February 2020.We take a look at some of the details around the buyback and the impact of the previous buyback on the share price over the buyback period.

Astellas Pharma

Astellas Pharma - Another Buyback